Regulatory Skeleton of Medical Devices in the European Union
Abstract
‘Medical device’ means any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination, for human beings, for one or more of the specific medical purpose(s). Medical devices make an essential contribution to healthcare in the Europe for the benefit of European citizens. These products must undergo a conformity assessment to demonstrate that they meet legal requirements to ensure they are safe and perform as intended. The European Medicines Agency (EMA) is responsible for the scientific evaluation of a product through centralized marketing authorisation applications (MAA). In order to commercialize medical devices in the European Union, a (European Conformity) CE Mark certificate is needed.
Downloads
References
https://www.ema.europa.eu/en/human-regulatory/overview/medical-devices
2. KOBRIDGE-Europe Medical Device Registration [Internet]. Korea: Medical Device Registration; 2020 [cited 2023 Aug 13]. Available from:
https://kobridgeconsulting.com/europe-medical-device-registration
3. EMERGO, by UL. Global: Europe CE Marking Regulatory Process for Medical Devices [Internet].EMERGO; 2019 [cited 2023 Aug 13]. Available from:
https://www.emergobyul.com/resources/europe-process chart#:~:text=In%20order%20to%20commercialize%20medical,they%20apply%20to%20your%20product
4. Max Stralin. CE check Support. Classification of Medical Devices and their Routes to CE Marking [Internet]. 2020 Jan [cited 2023 Aug 13]. Available from:
https://support.ce-check.eu/hc/en-us/articles/360008712879-Classification-Of-Medical-Devices-And-Their-Routes-To-CE-Marking
5. British Standards Institute. Ibim Tariah Technical Expert: BSI Americas Rebecca Pine, Medical Devices Consultant. Effective Post-market Surveillance: BSI/UK/440/ST/ 0614/en/HL [Internet]. [cited 2023 Aug 13]. Available from:
https://bsigroup.com
6. EUROPA, EUR-Lex-02017R0745-20170505EN. Regulation (EU) 2017/745 of the European Parliament and of the Council: EU [Internet]. eur-lex; 2020 Apr 24 [cited 2023 Aug 13]. Available from:
https://eur-lex.europa.eu/eli/reg/2017/745/2017-05-05
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
